z-logo
open-access-imgOpen Access
Invasive Oral Procedures and Events in Postmenopausal Women With Osteoporosis Treated With Denosumab for Up to 10 Years
Author(s) -
Nelson B. Watts,
John T. Grbic,
Neil Binkley,
Socrates E. Papapoulos,
Peter Butler,
Xiang Yin,
Antoniette Tierney,
Rachel B. Wagman,
Michael R. McClung
Publication year - 2019
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2018-01965
Subject(s) - denosumab , medicine , osteonecrosis of the jaw , incidence (geometry) , adverse effect , osteoporosis , placebo , randomized controlled trial , clinical trial , surgery , dentistry , bisphosphonate , alternative medicine , physics , pathology , optics
Antiresorptive therapy has been associated with osteonecrosis of the jaw (ONJ), an infrequent but potentially serious adverse event.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom